Across TCGA pan-cancer cohorts, RPS3AP9 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPS3AP9’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RPS3AP9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS3AP9 is over-expressed in tumor.
UCEC and COAD are the cancer types where RPS3AP9 tumor–normal differential expression is most reproducible.